Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37101392 | PubTator, text mining | PubMed |
| A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials. | Pharmaceut Med | 2023 | 37099245 | PubTator, text mining | PubMed |
| Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study. | Eur Radiol Exp | 2023 | 37093398 | PubTator, text mining | PubMed |
| Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling. | ACS Omega | 2023 | 37091368 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. | Front Pharmacol | 2023 | 37089922 | PubTator, text mining | PubMed |
| Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modeling. | Clin Transl Sci | 2023 | 37085998 | PubTator, text mining | PubMed |
| Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease. | Neurology | 2023 | 37085326 | PubTator, text mining | PubMed |
| Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. | World J Gastroenterol | 2023 | 37077517 | PubTator, text mining | PubMed |
| RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. | Cell Death Dis | 2023 | 37072399 | PubTator, text mining | PubMed |
| Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. | J Exp Clin Cancer Res | 2023 | 37055842 | PubTator, text mining | PubMed |
| Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. | Int J Mol Sci | 2023 | 37047633 | PubTator, text mining | PubMed |
| Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis. | Diagnostics (Basel) | 2023 | 37046429 | PubTator, text mining | PubMed |
| Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration. | J Antimicrob Chemother | 2023 | 37042359 | PubTator, text mining | PubMed |
| Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer. | Invest New Drugs | 2023 | 37036582 | PubTator, text mining | PubMed |
| Recommendations on the use of azole antifungals in hematology-oncology patients. | Rev Esp Quimioter | 2023 | 37017117 | PubTator, text mining | PubMed |
| The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins. | Biomed Pharmacother | 2023 | 37004323 | PubTator, text mining | PubMed |
Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions. | Pharmaceutics | 2023 | 36986880 | PubTator, text mining | PubMed |
| Possible Side Effects of Polyphenols and Their Interactions with Medicines. | Molecules | 2023 | 36985507 | PubTator, text mining | PubMed |
| Organic Anion Transporting Polypeptide 3A1 (OATP3A1)-Gated Bio-Orthogonal Labeling of Intracellular Proteins. | Molecules | 2023 | 36985493 | PubTator, text mining | PubMed |
| Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study. | Medicina (Kaunas) | 2023 | 36984480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=16